Tower Research Capital LLC (Trc) Oragenics Inc Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.11 - $15.59 $4,454 - $631,348	40,497 Added 98.75%	81,505 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.23 - $14.18 $8,264 - $509,515	35,932 Added 707.88%	41,008 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.24 - $0.42 $1,218 - $2,131	5,076 New	5,076 $2,000
Q2 2021 Aug 16, 2021	SELL	$0.6 - $0.89 $17,446 - $25,878	-29,077 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.52 - $1.52 $3,050 - $8,916	5,866 Added 25.27%	29,077 $26,000
Q4 2020 Feb 16, 2021	BUY	$0.39 - $0.6 $9,052 - $13,926	23,211 New	23,211 $10,000
Q3 2020 Nov 16, 2020	SELL	$0.56 - $1.49 $5,628 - $14,974	-10,050 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.39 - $0.83 $3,919 - $8,341	10,050 New	10,050 $7,000

Ticker OGEN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 116,395,000
Market Cap $41.9M
Description
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immuni...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.